HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Nakashima Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

10/2005[The effect of multimodality induction therapy for locally advanced non-small cell lung cancer].
11/2001Expression of the cdc25B gene as a prognosis marker in non-small cell lung cancer.
11/2001Expression of the protein gene product 9.5, PGP9.5, is correlated with T-status in non-small cell lung cancer.
10/2001Expression of the antiapoptosis gene, AAC-11, as a prognosis marker in non-small cell lung cancer.
8/2001Expression of Periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Nakashima Research Topics

Disease

16Neoplasms (Cancer)
08/2017 - 02/2000
6Osteonecrosis (Kienbock's Disease)
11/2017 - 06/2007
6Hepatocellular Carcinoma (Hepatoma)
05/2005 - 07/2000
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2005 - 08/2001
4Esophageal Neoplasms (Esophageal Cancer)
10/2021 - 01/2001
4Infections
02/2019 - 07/2001
4Neoplasm Metastasis (Metastasis)
09/2011 - 12/2001
4Carcinoma (Carcinomatosis)
02/2003 - 11/2000
4Fibrosis (Cirrhosis)
11/2001 - 04/2001
3Constipation
01/2018 - 06/2017
3Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2018 - 06/2017
3Coronary Artery Disease (Coronary Atherosclerosis)
06/2003 - 01/2000
3Thymoma (Thymic Carcinoma)
02/2003 - 01/2001
3Atrial Fibrillation
11/2000 - 09/2000
2Body Weight (Weight, Body)
10/2021 - 03/2001
2Diarrhea
01/2018 - 06/2017
2Necrosis
01/2016 - 09/2008
2Rheumatoid Arthritis
06/2008 - 09/2001
2Lymphatic Metastasis
12/2001 - 01/2001
2Lung Neoplasms (Lung Cancer)
12/2001 - 08/2001
2Hypertension (High Blood Pressure)
11/2001 - 01/2000
2Chlamydophila Infections
11/2001 - 10/2001
2Inflammation (Inflammations)
11/2001 - 10/2001
2Atherosclerosis
07/2001 - 10/2000
1Stomatitis
10/2021
1Whooping Cough (Pertussis)
02/2019
1Chronic Cough
02/2019
1Tetanus
02/2019
1Diphtheria
02/2019
1Abdominal Pain (Pain, Abdominal)
06/2017
1Osteophyte
02/2017
1Esophageal Squamous Cell Carcinoma
02/2017
1Vasculitis (Vasculitides)
11/2016
1Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
03/2016
1Contracture
02/2016
1Congenital Abnormalities (Deformity)
01/2016
1Neutropenia
10/2015
1Carcinogenesis
04/2014
1Osteoarthritis
11/2011

Drug/Important Bio-Agent (IBA)

10Messenger RNA (mRNA)IBA
09/2011 - 06/2001
8Proteins (Proteins, Gene)FDA Link
09/2011 - 02/2000
4CollagenIBA
02/2017 - 04/2001
4EnzymesIBA
02/2017 - 07/2000
4DNA (Deoxyribonucleic Acid)IBA
04/2014 - 01/2002
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2001 - 01/2000
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2017 - 01/2000
3Biological ProductsIBA
09/2011 - 12/2001
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2008 - 11/2000
3Hydroxyproline (4 Hydroxyproline)IBA
11/2001 - 04/2001
3Dimethylnitrosamine (Nitrosodimethylamine)IBA
11/2001 - 04/2001
3pilsicainideIBA
11/2000 - 09/2000
2linaclotideIBA
01/2018 - 01/2018
2ParaffinIBA
09/2011 - 02/2000
2RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
06/2008 - 08/2001
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
02/2006 - 11/2001
2Hepatitis B Surface Antigens (HBsAg)FDA Link
05/2005 - 12/2000
2Tissue Inhibitor of Metalloproteinase-1IBA
02/2003 - 06/2001
2Matrix Metalloproteinases (MMPs)IBA
02/2003 - 06/2001
2Pharmaceutical PreparationsIBA
12/2001 - 02/2000
2Anti-Arrhythmia AgentsIBA
10/2000 - 09/2000
1Cisplatin (Platino)FDA LinkGeneric
10/2021
1C-Reactive ProteinIBA
10/2021
1Fluorouracil (Carac)FDA LinkGeneric
10/2021
1Docetaxel (Taxotere)FDA Link
10/2021
1Prealbumin (Transthyretin)IBA
10/2021
1Immunoglobulin G (IgG)IBA
02/2019
1VaccinesIBA
02/2019
1Pertussis VaccineIBA
02/2019
1Serotonin (5 Hydroxytryptamine)IBA
06/2017
1ramosetron (Nasea)IBA
06/2017
1Transforming Growth Factors (Transforming Growth Factor)IBA
02/2017
1Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA
02/2017
1Anabolic AgentsIBA
02/2017
1fluorexon (calcein)IBA
02/2017
1Insulin-Like PeptidesIBA
02/2017
1Conditioned Culture MediaIBA
02/2017
1Phosphates (Orthophosphate)IBA
02/2017
1ImmunosorbentsIBA
02/2017
1Differentiation AntigensIBA
02/2017
1Pathogen-Associated Molecular Pattern MoleculesIBA
11/2016
1InflammasomesIBA
11/2016
1Monoclonal AntibodiesIBA
03/2016
1mogamulizumabIBA
03/2016
1CCR4 ReceptorsIBA
03/2016
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2016
1FluoroquinolonesIBA
10/2015
1Indicators and Reagents (Reagents)IBA
04/2014
18-Hydroxy-2'-DeoxyguanosineIBA
04/2014

Therapy/Procedure

8Therapeutics
10/2021 - 05/2000
7Osteotomy
11/2017 - 06/2007
6Drug Therapy (Chemotherapy)
10/2021 - 10/2000
2Radiotherapy
02/2017 - 04/2009
2Transplantation
10/2015 - 06/2001
2Esophagectomy
01/2015 - 01/2001
2Renal Dialysis (Hemodialysis)
06/2003 - 03/2001
1Chemoradiotherapy
02/2017
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
03/2016
1Injections
02/2016
1Hip Replacement Arthroplasty (Total Hip Replacement)
01/2016
1Hematopoietic Stem Cell Transplantation
10/2015